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Introduction
Eukaryotic cells undergo major reorganizations of their cyto-
skeleton during cell cycle transitions from interphase to mitosis 
and vice versa. Because cells reorganize many shared cytoskel-
etal elements such as actin in the transition between interphase 
and mitosis, they must have mechanisms to ensure both a rapid 
and decisive switch between the two states. Although there has 
been considerable study of how cells assemble the various cyto-
skeletal structures during each cell cycle stage, it remains un-
clear how the transition between stages is coordinated.
The fission yeast Schizosaccharomyces pombe has proven 
to be an excellent model to study cell cycle–dependent cytoskel-
etal arrangements (Roberts-Galbraith and Gould, 2008; Martin, 
2009). This cylindrical eukaryote grows from both ends in inter-
phase by polarization of actin patches and cables toward the 
growing tips of the cell (Snell and Nurse, 1993). However, the 
polarized actin distribution is lost with the onset of mitosis when 
growth ceases and actin is relocalized to the cell middle to form 
the actomyosin contractile ring. A conserved signaling network 
called the MOR is essential for polarized growth in interphase 
because MOR mutants have depolarized actin and become 
spherical in morphology. The MOR regulates cell polarity at 
least in part through control of spatial regulation of the Cdc42 
GTPase (Das et al., 2009). The MOR pathway is comprised of 
several proteins including Pmo25 (MO25 in humans; Kanai 
et al., 2005; Mendoza et al., 2005; Kume et al., 2007), Nak1 
(a GC kinase; Kanai et al., 2005; Leonhard and Nurse, 2005), 
and the homologue of the Drosophila Furry protein called Mor2 
(Cong et al., 2001; Hirata et al., 2002), all of which are required 
for the activity of the NDR kinase Orb6 (Verde et al., 1998; 
Tamaskovic et al., 2003; Imai et al., 2004; Kanai et al., 2005), the 
most downstream component of the pathway.
Interestingly, Sid2, the other NDR family kinase in fission 
yeast, acts at the end of the SIN signaling pathway (Sparks 
et al., 1999). The SIN is essential for stable actomyosin ring 
formation, ring constriction, and septum formation during 
The mechanisms that regulate cytoskeletal remodel-ing during the transition between mitosis and inter-phase are poorly understood. In fission yeast the 
MOR pathway promotes actin polarization to cell tips in 
interphase, whereas the SIN signaling pathway drives 
actomyosin ring assembly and cytokinesis. We show that 
the SIN inhibits MOR signaling in mitosis by interfering 
with Nak1 kinase-mediated activation of the most down-
stream MOR component, the NDR family kinase Orb6. 
Inactivation of the MOR may be a key function of the SIN 
because attenuation of MOR signaling rescued the cyto-
kinetic defects of SIN mutants and allowed weak SIN sig-
naling to trigger ectopic cytokinesis. Furthermore, failure 
to inhibit the MOR is toxic when the cell division appara-
tus is compromised. Together, our results reveal a mutually 
antagonistic relationship between the SIN and MOR path-
ways, which is important for completion of cytokinesis 
and coordination of cytoskeletal remodeling at the mitosis-
to-interphase transition.
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cdc16-116 and cdc15-140 cdc16-116 cells. Upon shift to the 
restrictive temperature, the double-mutant cells had a dispersed 
actin cytoskeleton (Fig. 1 B and Fig. S1, B and C), suggesting 
that SIN signaling disrupted interphase polarity. To rule out the 
possibility that Cdc16 inactivation could trigger an alternative 
pathway besides the SIN or that the cdc3-124 ring mutation dis-
rupts interphase polarity, we inactivated the most downstream 
SIN component Sid2 using the sid2-250 mutation. The cdc3-124 
cdc16-116 sid2-250 cells showed no block in cell elongation and 
nuclear division at the restrictive temperature and became long 
and multi-nucleate with actin polarized at the cell tips (Fig. 1, 
A and B; Fig. S1, B and C; Table I), confirming that the effects 
of Cdc16 inactivation are caused by ectopic activation of 
SIN signaling.
The G2 arrest observed after SIN activation is presumably 
mediated by inhibitory phosphorylation on Cdk1 because the 
nuclear division arrest was lost when the Cdk1 inhibitory kinase 
Wee1 was inactivated (Fig. 1 A). Interestingly, examination of 
cdc3-124 cdc16-116 wee1-50 cells at the restrictive temperature 
showed that although the wee1-50 mutation overcame the nu-
clear division block caused by SIN signaling, these cells failed 
to elongate and had depolarized actin (Table I; Fig. 1 B; Fig. S1, 
B and C), showing that the wee1-50 mutation did not overcome 
the SIN-mediated inhibition of polarized growth. Thus, SIN in-
hibition of nuclear division can be uncoupled from its inhibition 
of interphase actin organization.
The SIN inhibits the activity of the MOR 
pathway kinase Orb6
The phenotype caused by ectopic activation of the SIN is very 
similar to that observed in MOR pathway loss of function mu-
tants, which arrest with depolarized actin, fail to elongate, and 
undergo a Wee1-dependent G2 arrest (Hirata et al., 2002; Kanai 
et al., 2005). In fact, inactivation of the most downstream MOR 
pathway component Orb6 caused a block in cell elongation and 
nuclear division along with an increase in cell diameter in cdc3-
124 cdc16-116 sid2-250 cells similar to that in the cdc3-124 
cdc16-116 double mutant (Fig. 1 A and Table I). Consistent with 
the block in cell elongation, the actin cytoskeleton was depolar-
ized in the cdc3-124 cdc16-116 sid2-250 orb6-25 cells (Fig. 1 B). 
These results suggested that the SIN might disrupt interphase po-
larity by inhibiting the MOR pathway.
The most downstream component of the MOR pathway 
is the NDR family kinase Orb6, allowing the kinase activity of 
Orb6 to serve as a read-out for the functional status of the 
MOR pathway. To directly test if SIN activation blocks MOR 
signaling, we examined the kinase activity of Orb6 after ec-
topic activation of the SIN using the cdc16-116 mutation. 
As before, the cdc15-140 mutation was included to overcome 
complications due to constitutive septation in the cdc16-116 
cells. In contrast to asynchronous wild-type and G2-arrested 
cdc25-22 cells, the cdc16-116 cells, which also arrest in G2, 
showed reduced Orb6 activity, with or without the cdc15-140 
mutation (Fig. 2 A). We next examined if SIN activation had 
a similar effect in interphase-arrested cells. Interestingly, 
although cdc15-140 cdc25-22 cells maintained high Orb6 
activity consistent with their bipolar growth in interphase, SIN 
cytokinesis (Krapp and Simanis, 2008). Although the two NDR 
kinase pathways, MOR and SIN, are essential for separate cyto-
skeletal configurations, the mechanism that controls the switch 
between the two states remains unknown. Interestingly, an ear-
lier study suggested that the SIN inhibits actin polarization toward 
cell tips (Mishra et al., 2004); however, the mechanism of SIN 
action was unclear.
In this study we show that the SIN can directly inhibit po-
larized growth by blocking MOR pathway signaling. Our data 
further suggest that this cross talk between the SIN and MOR 
pathways is important to coordinate cytoskeletal rearrange-
ments during the transition from mitosis to interphase.
Results
SIN activation in interphase arrests 
nuclear division and inhibits the  
polarity machinery
To examine how the SIN affects interphase polarity and cell 
cycle progression we ectopically activated the SIN in interphase. 
The SIN can be turned on by inactivation of Cdc16, which is the 
GAP for the Spg1 GTPase (Fankhauser et al., 1993; Schmidt 
et al., 1997). If the SIN is activated in asynchronous cells, the cells 
stop polarized growth because they cease to elongate, and arrest 
as mononucleate or binucleate cells with multiple septa (Minet 
et al., 1979; Fankhauser et al., 1993). The disruption of polarized 
growth in these cells could be an indirect effect caused by ectopic 
septa formation, which could interfere with growth at cell 
ends or cause cell death by cutting the nuclei in half. To remove 
potential complications due to formation of multiple septa, the 
SIN was activated using the cdc16-116 temperature-sensitive 
mutant in either the cdc3-124 or cdc15-140 temperature- 
sensitive mutant background. The cdc3-124 and cdc15-140 mu-
tations block cytokinesis and septum formation by disrupting 
actomyosin ring assembly, but do not interfere with SIN signal-
ing (Balasubramanian et al., 1994; Fankhauser et al., 1995; 
Sparks et al., 1999). The cdc16-116 cdc3-124 and cdc16-116 
cdc15-140 strains were shifted to restrictive conditions for 4 h 
(almost two cell cycles) and were scored for cell length and 
number of nuclei. Because the cdc3-124 and cdc15-140 muta-
tions block cytokinesis, the cdc16-116 cdc3-124 and cdc16-116 
cdc15-140 cells should be tetranucleate and twice the length of 
normal wild-type cells if nuclear division and cell growth pro-
ceeded normally. Interestingly, the cdc16-116 cdc3-124 and 
cdc16-116 cdc15-140 double-mutant cells arrested as both 
mono- and binucleate cells and failed to elongate past the size of 
asynchronous wild-type cells (Fig. 1 A, Table I). These cells also 
displayed an increase in cell diameter consistent with a disrup-
tion in polarized growth (Table I). FACS analysis showed that 
the cells were arrested with 2C and 4C peaks of similar size to 
the mono- and binucleate peaks, consistent with each nuclei ar-
resting with a G2 DNA content (Fig. S1 A). Thus, SIN activation 
blocked cell elongation and mitotic entry in interphase cells.
Cell elongation in interphase requires polarization of actin 
patches to the cell tips. To test if the block in cell elongation 
upon SIN activation is due to inhibition of the interphase polarity 
machinery, we looked at the actin distribution in the cdc3-124 
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cells, Orb6 kinase activity peaks in G2 phase and then decreases 
as cells go through mitosis and septation (Kanai et al., 2005). 
Interestingly, the interphase peak in Orb6 activity after cell divi-
sion was shown to require the activity of some of the SIN com-
ponents such as Cdc7 in the previous mitosis (Kanai et al., 2005), 
apparently contradicting our results showing that ectopic SIN 
activation in this mutant background using the cdc16-116 mu-
tation inhibited Orb6 activity (Fig. 2 A). Hence, SIN activa-
tion in interphase results in loss of Orb6 kinase activity and 
blocks MOR signaling.
We next examined the relationship between the SIN and Orb6 
activity under more physiological circumstances. In wild-type 
Figure 1. SIN activation arrests nuclear division 
and inhibits the interphase polarity machinery.  
(A) Cells of the indicated genotypes were grown at 
25°C and then shifted to 36°C for 4 h, methanol 
fixed, stained with DAPI, and scored for number 
of nuclei (n). The experiment was done in triplicate 
and error bars denote SD. (B) Cells of the indi-
cated genotypes were shifted to 36°C for 4 h and 
then stained with Alexa Fluor 488–phalloidin and 
DAPI to visualize actin and DNA, respectively. 
Dashed dividing lines separate individual images 
for montage presentations.
JCB • VOLUME 190 • NUMBER 5 • 2010 796
high during cytokinesis when the SIN is active (Kanai et al., 
2005). To test this possibility in another way, we examined Nak1 
kinase activity in cdc3-124 cdc16-116 cells, which arrest with 
active SIN. Consistent with earlier results, upon SIN activa-
tion there was no significant reduction in Nak1 kinase activity 
(Fig. 3 A). This result suggested that the SIN did not alter Nak1 
kinase activity, per se, but possibly disrupted the ability of Nak1 
to activate Orb6.
The exact mechanism by which Nak1 activates Orb6 re-
mains unclear. Although interaction between the two proteins 
was not observed by coimmunoprecipitation, a two-hybrid inter-
action was observed (Kanai et al., 2005), suggesting a physical 
association between the two proteins. This raised the possibility 
that the SIN might interfere with Nak1-mediated activation of 
Orb6 by preventing association of the two proteins. To test this 
hypothesis, we constructed a Nak1–Orb6 fusion (Fig. 3 B). The 
Nak1–Orb6 fusion was able to rescue the growth defects of both 
the Nak1 and Orb6 single mutants (Table II), suggesting that the 
individual proteins in the fusion retained functionality. The 
fusion did not rescue a mutant in the upstream regulator Pmo25, 
consistent with the known dependence of Nak1 activity on 
Pmo25 (Kanai et al., 2005). Interestingly, the fusion, but not the 
Nak1 and Orb6 proteins individually or in combination, com-
pletely rescued a mutation in the scaffold protein Mor2, suggest-
ing that the key function of Mor2 is to bring Nak1 and Orb6 
together (Table II).
To test whether the Nak1–Orb6 fusion could bypass the 
block in cell elongation when the SIN is activated, we expressed 
the Nak1–Orb6 fusion in cdc3-124 cdc16-116 background. 
Unlike cdc3-124 cdc16-116 cells carrying the vector control 
plasmid, which did not elongate, the cdc3-124 cdc16-116 cells 
containing the Nak1–Orb6 fusion plasmid were able to undergo 
significant elongation (Fig. 3 C). The cdc3-124 cdc16-116 cells 
expressing the Nak1–Orb6 fusion were able to polarize actin to 
the cell tips, but also showed medial actin distribution consis-
tent with the cells trying to carry out both the SIN and MOR 
activation inhibits Orb6. However, careful examination of 
Orb6 kinase activity in synchronous cdc7-24 mutant cells re-
solved the apparent discrepancy. Consistent with the earlier re-
sults, Cdc7 was required for the large peak in the Orb6 activity 
after completion of mitosis (Fig. 2 B, compare 200–240-min 
time points in wild-type and cdc7-24 cells). However, cdc7-24 
cells maintained moderate levels of Orb6 activity, consistent with 
the continued polarized growth observed in cdc7-24 mutants. 
Thus, the SIN is not essential for Orb6 activity, per se, but is re-
quired for the peak in activity associated with the onset of bipolar 
growth in the following cell cycle. We next examined Orb6 activ-
ity in synchronous cdc15-140 mutants. The cdc15-140 mutant 
cells have defects in actomyosin ring assembly, which triggers 
the cytokinesis checkpoint, causing them to arrest as binucleate 
cells with activated SIN (Liu et al., 2000; Mishra et al., 2004). 
Interestingly, these cells maintained very low Orb6 kinase activ-
ity consistent with the SIN inhibiting Orb6 (Fig. 2, A and B; 
160–240 min in cdc15-140). If Cdc7 is inactivated in these cells, 
they regained moderate levels of Orb6 kinase activity (Fig. 2 B, 
compare 160–240-min time points in cdc15-140 cdc7-24 and 
cdc15-140 cells) but lacked the peak in the following interphase 
(Fig. 2 B, compare 200–240-min time points in cdc15-140 cdc7-24 
and wild-type cells). Thus, SIN has a dual role in regulation of 
the MOR pathway. The SIN suppresses Orb6 activity during 
cytokinesis but is required for its later increase as cells begin new 
end growth in the next cell cycle after cytokinesis.
The SIN inhibits the MOR pathway by 
blocking Nak1-mediated activation of Orb6
We next wanted to understand the mechanism by which the SIN 
inhibits Orb6 kinase activity. Similar to other members of the 
NDR kinase family, Orb6 kinase is activated by the GC kinase 
Nak1 (Kanai et al., 2005; Hergovich et al., 2006). Thus, the SIN 
could either inhibit the activity of Nak1, or it could inhibit the 
ability of Nak1 to activate Orb6. A previous study suggested that 
the SIN does not inhibit Nak1 because Nak1 activity remained 
Table I. Activation of the SIN inhibits polarized cell growth
Strain genotype Number of nuclei (n) Mean cell length ± SD Mean cell diameter ± SD
(m) (m)
wild type n = 1 11.9 ± 1.8 2.93 ± 0.2
n = 2 14.9 ± 0.817 2.95 ± 0.35
cdc3-124 cdc16-116 n = 1 10.66 ± 2 4.62 ± 0.46
n = 2 13.75 ± 2 4.7 ± 0.5
cdc15-140 cdc16-116 n = 1 10.2 ± 2 6.46 ± 1.26
n = 2 15 ± 1 6.086 ± 1.24
cdc3-124 cdc16-116 wee1-50 n = 1 6.65 ± 0.85 4.81 ± 0.45
n = 2 7.25 ± 1.4 4.43 ± 0.54
n = 4 9.6 ± 1.6 4.47 ± 0.61
cdc3-124 cdc16-116sid2-250 n = 1 N/A N/A
n = 2 21.2 ± 1.75 3.47 ± 0.36
n = 4 26 ± 4 3.6 ± 0.434
cdc3-124 cdc16-116 sid2-250 orb6-25 n = 1 7.86 ± 1.5 5.04 ± 0.41
n = 2 13.23 ± 3 5.3 ± 0.365
n = 4 14.38 ± 1 8.23 ± 1.13
Average length and diameter measurements for cells with indicated genotype and the given number of nuclei are shown. SD, standard deviation. Measurements are 
not shown (N/A) if the strain did not arrest with a significant number of cells with the indicated number of nuclei. At least 100 cells were counted for each strain.
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polarization defects observed in these cells (Fig. 3, C and D), 
showing that fusion of Nak1 and Orb6 was required to bypass 
the SIN-mediated inhibition of polarized growth. Furthermore, 
actin polarization programs (Fig. 3 D). Expression of Nak1 or 
Orb6 alone or coexpression of both Nak1 and Orb6 in the cdc3-
124 cdc16-116 cells did not bypass the cell elongation and actin 
Figure 2. The SIN has a dual role in regulation of the Orb6 kinase activity. (A) Ectopic activation of the SIN in interphase inhibits Orb6 kinase activity. All 
strains expressed mob2-13Myc from the chromosomal promoter. Cells were grown at 25°C, then shifted to 36°C for 3 h. Cell extracts were prepared and 
the Orb6–Mob2–13Myc complex was immunoprecipitated using anti-Myc antibodies. Immunoprecipitates were split, with one half immunoblotted with 
anti-Myc antibodies and the other half used to assay Orb6 kinase activity using MBP as an artificial substrate. The kinase activities (KA) were quantified 
using ImageJ software and normalized to the amount of Mob2–13Myc (IP) and the background kinase activity in untagged control cells. The activity rela-
tive to wild-type cells is shown. Error bars denote SD from three separate experiments. (B) The SIN inhibits Orb6 kinase activity in mitosis but promotes its 
full activity in the following interphase. Early G2 cells of the indicated strains expressing Mob2-13Myc from the chromosomal locus were grown at 25°C, 
synchronized by elutriation, and then shifted to 36°C at time zero, and portions were collected at the indicated times and assayed for Orb6 kinase activity. 
This experiment was repeated at least once with similar results.
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Figure 3. Fusion of Nak1 to Orb6 bypasses SIN inhibition of cell elongation. (A) The SIN does not inhibit Nak1 activity. Wild-type and cdc3-124 cdc16-116 
cells expressing Nak1-3GFP from the chromosomal promoter were grown at 25°C and then shifted to 36°C for 3 h before harvesting. Cell extracts were 
prepared and Nak1-3GFP was immunoprecipitated with anti-GFP (Invitrogen) antibody. The immunoprecipitates were split, with one portion used for 
Western blotting using GFP antibodies (Santa Cruz Biotechnology, Inc.) (IP), and the other portion for in vitro kinase assays using -casein (Sigma-Aldrich) 
as an artificial substrate (Leonhard and Nurse, 2005). The kinase activity (KA) was measured using a PhosphorImager (MDS Analytical Technologies), 
quantified using ImageQuant software, and normalized to the amount of Nak1 (IP). The activity relative to wild-type cells is shown. The difference in the 
normalized Nak1 kinase activity between the wild-type and the cdc3-124 cdc16-116 cells was not significant based on t test analysis from three different 
experiments. Error bars denote SD of the relative KA. (B) Schematic representation of the Nak1–Orb6 fusion construct expressed from the medium strength 
thiamine-repressible promoter, nmt41. (C) cdc3-124 cdc16-116 cells carrying the indicated plasmids were induced for 19 h in media lacking thiamine 
and shifted to 36°C; then cells were collected at 2, 4, and 7 h. The plasmids used were the pRep41 vector, or the pRep41 vector carrying Nak1, Orb6, 
the Nak1–Orb6 fusion (fusion), the Nak1 kinase-dead–Orb6 fusion (Nak1*-Orb6), or the Nak1 and Orb6 genes on separate plasmids (Nak1 + Orb6). 
Cells were then stained with DAPI and scored for cell length measurements (top panel) and nuclei count (n, bottom panel). Error bars in the cell length plot 
denote SD of the length measurements obtained from three separate experiments. Average cell length was compared between cells with vector control and 
those with the different transgenes as indicated in the figure at each time point. Statistically significant increase in cell length (based on P-value calculation 
by t test analysis) was observed only in cells expressing the fusion construct. *, P = 0.0118; **, P = 0.0001. At least 100 cells were analyzed for each 
time point. For clarity, the SD values for the nuclear count plot are shown in Fig. S4. (D) cdc3-124 cdc16-116 cells with the indicated transgenes were 
grown as in C and then processed for actin staining. Montage of representative cells (separated by dashed dividing lines) with actin (phalloidin staining) 
and nuclei (DAPI staining) staining are shown for the 7-h time point.
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During the delay the SIN remains active, causing an arrest in 
polarized growth and nuclear division until cytokinesis is com-
plete (Mishra et al., 2004). We found that expression of the 
Nak1–Orb6 fusion in wild-type cells treated with low doses of 
Lat B is lethal (Fig. 4 B). Examination of similarly treated wild-
type cells in liquid culture showed that wild-type cells with the 
vector control initially accumulate binucleate cells because of 
the delay in cytokinesis, but are eventually able to divide as 
judged by their ability to maintain a population of mononucle-
ate cells and failure to accumulate multinucleate cells (Fig. 4, 
C and D). In contrast, wild-type cells expressing the fusion pro-
tein are unable to complete cytokinesis as seen by the loss of 
mononucleate cells and the accumulation of multinucleate cells 
(Fig. 4, C and D). This phenotype could be caused by loss of 
SIN signaling, which also causes cells to fail cytokinesis and 
become multinucleate when cytokinesis is delayed (Mishra 
et al., 2004), or the Nak1–Orb6 fusion could be interfering with 
the cytokinetic apparatus, keeping cells from completing cyto-
kinesis. We do not think that expression of the fusion protein is 
interfering with SIN signaling because the cells expressing the 
fusion maintained similar levels of SIN activity as those with 
the control vector, as judged by the presence of the SIN kinase 
Cdc7 at the SPB.
We also used another approach to test whether the Nak1–
Orb6 fusion was affecting SIN signaling. We completely blocked 
cytokinesis using the cdc3-124 profilin mutant, which cannot 
form actomyosin rings. After shift to restrictive temperature, 
these cells undergo a prolonged SIN-dependent arrest as bi-
nucleates but eventually leak past the nuclear division arrest and 
become multinucleate (Trautmann et al., 2001). Expression of 
the Nak1–Orb6 fusion in these cells did not significantly inter-
fere with the ability of these cells to arrest as binucleates, sug-
gesting that it was not affecting SIN signaling (Fig. 4 E), which 
is required to maintain the nuclear division arrest. Furthermore, 
examination of the kinase activity of the most downstream com-
ponent of the SIN pathway, Sid2, did not show a significant 
change when the Nak1–Orb6 fusion was expressed (Fig. 4 F). 
Along similar lines, we did not observe any evidence for persis-
tent SIN signaling when the MOR was inhibited in orb6-25 mu-
tants (Fig. S4). Together, these results suggest that the MOR 
pathway may interfere with actomyosin ring assembly and 
constriction downstream of the SIN, and that MOR inhibition is 
essential when the cell division machinery is compromised and 
cytokinesis is delayed.
Reduction in MOR activity allows weak SIN 
signaling to promote cytokinesis
If the MOR pathway interferes with the ability of the SIN to 
promote cytokinesis, then reduction in MOR pathway activity 
might be predicted to enhance cytokinesis in SIN mutants. 
Therefore, we tested the phenotype of double mutants between 
the MOR mutant orb6-25 and various SIN mutants. Interest-
ingly, the orb6-25 temperature-sensitive mutant was able to 
rescue the growth defect of some temperature-sensitive SIN 
mutants at 29°C and 33°C, which are semi-permissive tem-
peratures for orb6-25 (Fig. 5 A). Although the orb6-25 mutant 
dies at 36°C and was thus not able to rescue SIN mutants at 
the kinase activity of Nak1 was required in the fusion because a 
kinase inactivating mutation in Nak1 blocked the ability of the 
fusion to drive polarized growth when the SIN is active (Fig. 3, 
C and D). Interestingly, the Nak1–Orb6 fusion also partially 
overrode the block in nuclear division caused by SIN activation, 
as seen by the reduction in mononucleate and increase in bi- and 
tetranucleate cells compared with controls at the 7-h time point 
(Fig. 3 C). Because either MOR inactivation or SIN activation 
blocks both nuclear division and cell elongation, the ability of 
the Nak1–Orb6 fusion to partially bypass both of these blocks 
when the SIN is active suggests that the SIN might block both 
nuclear division and cell growth by inhibiting the MOR. The 
failure of the fusion to completely bypass the SIN-mediated 
block in growth and nuclear division suggests that the SIN can 
still partially inhibit the MOR in the presence of the fusion, or 
the SIN can affect nuclear division and cell growth through an 
additional mechanism besides inhibition of the MOR.
Failure to inhibit MOR pathway signaling 
interferes with cytokinesis
The previous results showed that the SIN blocks polarized 
growth during cytokinesis by inhibiting the MOR pathway. 
We next wanted to address why the SIN inhibits the MOR. 
One possibility is that the SIN might inhibit the MOR to keep it 
from interfering with cytokinesis by titrating shared cytoskeletal 
elements such as actin away from the cell division site and to-
ward the cell tips. To test whether loss of SIN inhibition of the 
MOR caused defects in cytokinesis, we examined the effects of 
expressing the Nak1–Orb6 fusion in different S. pombe strains. 
The fusion protein caused a very slight increase in cell length 
(Fig. S5 C), and surprisingly, expression of the Nak1–Orb6 fu-
sion had only mild effects on cytokinesis in wild-type cells (un-
published data), perhaps because expression of the fusion does 
not totally bypass SIN inhibition. To see if expression of the 
Nak1–Orb6 fusion might interfere with cytokinesis in a more 
sensitized background, we expressed the fusion in cells with 
compromised SIN signaling. Interestingly, expression of the fu-
sion was lethal when expressed in the temperature-sensitive 
SIN mutant sid2-250 at the semi-permissive temperature of 
29°C (Fig. 4 A). This result suggested that MOR inhibition 
becomes essential when cytokinesis is partially compromised. 
To further test this hypothesis we used an alternative way to 
interfere with the cell division machinery. Low doses of the 
actin-depolymerizing drug, latrunculin B (Lat B) causes a cell divi-
sion delay in wild-type cells (Trautmann and McCollum, 2005). 
Table II. Rescue of MOR pathway mutants by the Nak1–Orb6 fusion
Strain Vector Nak1 Orb6 Nak1–Orb6 
fusion
pmo25-35   N/A 
nak1-167  +  +
orb6-25  N/A + +
mor2-786    +
The ability of the Nak1–Orb6 fusion to rescue (+) or not rescue () MOR path-
way mutants at the restrictive temperature of 36°C is shown. N/A indicates 
condition that was not tested.
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relative to orb6-25 alone. Inactivation of orb6 was unable to pro-
mote septum formation in SIN double-mutant cells with muta-
tions in two different SIN components (sid2-250 sid1-239 and 
sid2-250 cdc11-123), which presumably completely ablates SIN 
signaling (Fig. 5 B), suggesting that inactivation of orb6 does not 
bypass the requirement of the SIN in septum formation, but in-
stead allows residual weak SIN signaling to promote cytokinesis.
To examine how loss of MOR activity rescued SIN mutants 
in more detail, we observed the dynamics of actomyosin ring as-
sembly and septum formation in orb6-25 sid2-250 double-mutant 
cells. Previous studies have shown that SIN mutants form acto-
myosin rings that fall apart in anaphase and the cells do not 
form septa (Krapp and Simanis, 2008). Therefore, we examined 
this temperature, examination of double mutants between 
orb6-25 and various SIN mutants at 36°C showed that the 
orb6-25 mutation was able to partially rescue the septum for-
mation defect in all SIN mutants tested (Fig. 5 B). We also ex-
amined this phenotype using sid2-250, orb6-25, and sid2-250 
orb6-25 cells that had been synchronized in G2 and then 
shifted to restrictive temperature (Fig. S5 A). Consistent with 
results from asynchronous cells, the sid2-250 orb6-25 cells 
showed a substantial increase in septation compared with the 
sid2-250 single-mutant cells, which totally failed in septation. 
Although MOR inactivation allowed septation in the sid2-250 
orb6-25 cells, absence of a completely functional SIN path-
way could explain the reduced septation index in these cells 
Figure 4. MOR inhibition becomes essential when cytokinesis is perturbed. (A) sid2-250 cells expressing the vector alone or the Nak1–Orb6 fusion 
transgene were grown in medium lacking thiamine for 14 h at 25°C to induce expression of the fusion protein before spotting 10-fold serial dilutions on 
minimal media plates lacking thiamine at the indicated temperatures. (B) Wild-type cells carrying the indicated plasmids were grown as in A and then 10-fold 
serial dilutions were spotted on minimal media plates with or without 6 µM Lat B and tested for growth at 25°C. (C) Wild-type cells carrying integrated 
copies of Cdc7-mcherry were transformed with the indicated plasmids, and grown as in A for 19 h before being treated with a low dose (4 µM) of Lat B. 
Samples were collected every 2 h for 8 h after drug addition (0 h). Cells were fixed, stained with DAPI, and scored for number of nuclei (n, top panel) and 
Cdc7 localization at the SPB (bottom panel). At least 100 cells were analyzed for nuclei count and at least 50 for scoring Cdc7-mcherry localization. Error 
bars denote SD for three separate experiments. (D) Representative images of the Cdc7-mcherry cells expressing vector alone or the Nak1–Orb6 fusion at 
the 7-h time point are shown. (E) cdc3-124 sid2-13Myc cells expressing either the empty vector control or the fusion protein were grown in media lacking 
thiamine for 19 h at 25°C and then shifted to 36°C. Samples were collected for DAPI stain and nuclei count every hour for 8 h after shift to 36°C. Error 
bars denote SD for three separate experiments. (F) Cells with the indicated genotypes were grown as in E and shifted to 36°C for 3 h. Cell extracts were 
prepared and Sid2-13Myc was immunoprecipitated with anti-Myc (Santa Cruz Biotechnology, Inc.) antibody. The immunoprecipitates were split, with one 
portion used for Western blotting using Myc antibodies (Santa Cruz Biotechnology, Inc.) (IP) and the other portion used for in vitro kinase assays using 
myelin basic protein (MBP; Sigma-Aldrich) as an artificial substrate as described previously (Sparks et al., 1999) and in Materials and methods. The kinase 
activity (KA) was measured using a PhosphorImager (MDS Analytical Technologies), quantified using ImageQuant software, and normalized to the amount 
of Sid2 (IP). The activity relative to cells with the control plasmid is shown. Error bars denote SD of the relative KA. The difference in Sid2 kinase activity 
between cells expressing the vector and those expressing the fusion protein was not statistically significant based on t test analysis from three different 
experiments. *, P = 0.1047.
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Figure 5. The MOR pathway mutant orb6-25 rescues growth and cell division defects of SIN mutants. (A) Cells of the indicated genotypes were grown at 
25°C and their growth was tested at the indicated temperatures by spotting 10-fold serial dilutions on YE agar plates. (B) Cells of the indicated genotypes 
were shifted to 36°C for 4 h, methanol fixed, and stained with Calcofluor White (CW) to score for septum formation. Representative cdc7-24 (montage) 
and cdc7-24 orb6-25 cells show the septation status in respective cells and arrows mark the septum. Dashed dividing lines separate the individual images 
in the montage. Arrows mark the septum in the cdc7-24 orb6-25 cells. The septation index (percentage of cells with septa) for all the genotypes indicated is 
shown in the histogram plot. At least 100 cells were scored for each strain. Error bars denote the SD for three separate experiments. (C) Time-lapse images 
of the indicated strains were acquired using a spinning disc confocal microscope (TE 2000-E2; Nikon). Cells were grown at 25°C and then placed on the 
microscope stage that was maintained at 36°C during the entire time of imaging. Arrowheads indicate completion of ring constriction in representative cells. 
(D) Cells of the indicated genotypes were grown as in B and the proportion of cells with ectopic septa (either septa present in mononucleate cells, or multiple 
septa) was scored. At least 100 cells were scored for each genotype. The experiment was done in triplicate and error bars denote the SD values. Arrows 
in the montage image point to the ectopic septa found in representative cells. Dashed dividing lines separate the individual images in the montage.
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Cross talk between the SIN and  
MOR pathways
The molecular details governing regulation of MOR/Orb6 
activity by the SIN are likely to be complex. Orb6 kinase activ-
ity normally peaks at about the time when cells initiate bipolar 
growth in early G2 phase, and then decreases during mitosis 
(Kanai et al., 2005). We suspect that the decrease of Orb6 activ-
ity during mitosis may be biphasic. The initial reduction in Orb6 
kinase activity at mitotic entry appears to be independent of 
the SIN because the SIN is not active in early mitosis (Guertin 
et al., 2000), and because Orb6 activity still dropped at mitotic 
entry in the SIN mutant cdc7-24 (Kanai et al., 2005; this paper). 
The initial drop in Orb6 activity may be triggered directly or 
indirectly by Cdk1 activation and mitotic entry, and then when 
Cdk1 activity drops in anaphase, the SIN becomes active and 
maintains inhibition of the MOR pathway until cytokinesis is 
complete. Intriguingly, some of the upstream SIN components 
are required for the increase in Orb6 activity that occurs in the 
following G2 phase when cells initiate growth at the new end 
(Kanai et al., 2005). The mechanistic details of how the SIN 
both activates and inhibits the MOR are as yet unclear. One ex-
planation for these results could be that the SIN causes both in-
hibitory and activating modifications in the MOR pathway, with 
the inhibitory modifications being dominant. Removal of the 
inhibitory modifications after cytokinesis would then allow the 
MOR to become active in interphase. To address this issue, fu-
ture studies will need to focus on identification of SIN-dependent 
changes in the levels or post-translational modifications of 
MOR components.
However, even without knowing the specific details of 
how the SIN affects the MOR pathway, our present data indi-
cate that the SIN blocks signaling through the MOR pathway by 
inhibiting activation of the most downstream component of the 
pathway, the NDR family kinase Orb6. Our results showed that 
the SIN does not affect the kinase activity of the Orb6-activating 
kinase Nak1, suggesting that the SIN interferes with the ability 
of Nak1 to activate Orb6. Previous reports have suggested that 
the protein Mor2, which is required for Orb6 kinase activity, 
functions as a scaffold to bring together Orb6 with its activator, 
the GC family kinase Nak1 (Kanai et al., 2005). Consistent with 
this idea, we found that fusion of Nak1 to Orb6 could rescue the 
mor2-786 mutant. Interestingly, the SIN inhibition of polarized 
actomyosin ring constriction and septum formation in the sid2-250 
orb6-25 double-mutant cells expressing the GFP-tagged actomyo-
sin ring component Rlc1 (Le Goff et al., 2000; Naqvi et al., 2000) 
at the restrictive temperature of 36°C using time-lapse microscopy. 
As expected, in wild-type cells, actomyosin rings formed then 
constricted (15/15 cells; Fig. 5 C). In contrast, actomyosin rings 
formed in sid2-250 single-mutant cells, but failed to constrict and 
then disassembled in 16 out of 21 cells observed (Fig. 5 C). Unlike 
sid2-250 mutant cells but similar to wild-type cells, actomyosin 
rings formed and constricted in sid2-250 orb6-25 double mutants 
(21/21 cells; Fig. 5 C). Thus, loss of Orb6 activity allows SIN 
mutants to maintain actomyosin ring stability and complete cyto-
kinesis. Thus, loss of MOR activity allows weak SIN signaling to 
promote actomyosin ring constriction and septum formation.
Interestingly, MOR inactivation also enhanced the ability 
of weak SIN signaling to promote ectopic septation. The Spg1-
GFP allele has a weakly activated SIN phenotype, which causes 
occasional formation of interphase septa, or additional rounds 
of septum formation after normal cytokinesis (García-Cortés 
and McCollum, 2009). When spg1-GFP was combined with 
orb6-25, or any other MOR mutant, the resulting double-mutant 
cells showed an increased rate of ectopic septum formation 
(Fig. 5 D). Together, these results show that reduction in MOR 
pathway activity enhances the ability of weak SIN signaling to 
promote cytokinesis.
Discussion
The SIN antagonizes interphase polarity 
through inhibition of the MOR pathway
The SIN is required for actomyosin ring assembly and septum 
synthesis (Balasubramanian et al., 1998; Simanis, 2003; Hachet 
and Simanis, 2008; Huang et al., 2008). Previous studies have 
shown that when perturbation of the actomyosin ring causes a 
delay in cytokinesis, SIN activity is maintained during the delay 
and is required for cells to continue to promote actomyosin 
ring assembly, block polarized growth, and arrest cells with 
two G2 phase nuclei in order to allow cells to complete cell di-
vision and maintain normal ploidy (Liu et al., 2000; Trautmann 
et al., 2001; Mishra et al., 2004). However, it was unclear how 
the effects of the SIN on cell polarity and nuclear division are 
mediated. Although part of the SIN inhibition of interphase po-
larity might be through competition for shared components, we 
demonstrated that SIN signaling clearly interferes with inter-
phase polarity through inhibition of the MOR pathway. Inter-
estingly, the ability of the SIN to inhibit G2/M transition might 
also be a consequence of inhibition of the MOR pathway be-
cause MOR pathway mutants, like cells with activated SIN, 
display a Wee1-dependent block in G2/M progression (Hirata 
et al., 2002; Kanai et al., 2005). Consistent with this idea, 
we found that blocking complete inhibition of the MOR by 
the SIN using the Nak1–Orb6 fusion could partially bypass the 
SIN-dependent block in nuclear division. The failure of the 
Nak1–Orb6 fusion to completely bypass the SIN inhibition 
of polarized growth and nuclear division could be because the 
SIN is still capable of partially inhibiting the MOR when the 
Nak1–Orb6 fusion is expressed.
Figure 6. Model. Antagonistic interaction between the SIN and MOR is 
essential to inhibit bipolar growth until the completion of cytokinesis and to 
prevent ectopic cytokinesis in interphase. Actin and associated cytoskeletal 
elements at the cell ends and cell middle are shown in red.
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Sid2 in mammals, called Lats1/2, function as tumor suppressors 
(Takahashi et al., 2005; Hergovich et al., 2006; Seidel et al., 
2007; Hao et al., 2008; Zhang et al., 2008). The role of Ndr1/2 
in human diseases such as cancer is just beginning to be re-
vealed (Hergovich et al., 2006, 2008). Thus, a detailed under-
standing of cross talk between NDR pathways will likely have 
important implications for our understanding of how cells regu-
late both growth and proliferation, as well as the cytoskeletal 
rearrangements that occur during the transitions between mito-
sis and interphase.
Materials and methods
Yeast strain culture and flow cytometry conditions
Fission yeast media, growth conditions, and manipulations were performed 
as described previously (Moreno et al., 1991). Except where noted, cells 
were grown in yeast extract (YE) medium. Flow cytometry analysis (FACS) 
was performed on isolated nuclei as described previously (Forsburg and 
Rhind, 2006) using a FACScan flow cytometer (BD).
Microscopy
GFP and fusion proteins were observed in cells that were grown in YE (unless 
otherwise mentioned) after fixation with 20°C methanol or in live cells for 
time-lapse studies. DNA and septum material were visualized by staining 
with DAPI (Sigma-Aldrich) and Calcofluor White (CW; Sigma-Aldrich), re-
spectively. Cell staining with DAPI and Alexa Fluor 488–conjugated phalloi-
din was performed as described previously (Balasubramanian et al., 1997). 
Images were acquired at room temperature using a microscope (Eclipse 
E600; Nikon) equipped with a cooled charge-coupled device camera 
(Orca-ER; Hamamatsu Photonics) and IPlab Spectrum software (Scanalytics). 
Z-series of images were captured with a 100x oil (NA 1.3) objective lens 
and 3D stacked view was obtained using IP Laboratory software. For time-
lapse studies, exponentially growing cells were concentrated and 1.8 µl of 
cell suspension (in YE) was placed on a microscope slide between a 2% 
YE-agar pad and a coverslip, which was sealed using VALAP. The cells were 
maintained at 36°C in a 20/20 Technologies micro-incubator, and images 
were acquired on an inverted microscope (TE 2000-E2; Nikon) equipped 
with a spinning disk confocal system (CSU10B; Solamere Technology Group) 
controlled by MetaMorph software. Time-lapse Z-series of images was cap-
tured with a 60x Plan Apo oil objective (NA 1.4; Nikon) using a camera 
(MGi EMCCD; Rolera) and processed using MetaMorph software to get the 
maximum projection of the z-stack images.
Plasmid construction
The fusion construct between the Nak1 and Orb6 genes was expressed in 
the pREP41-GFP vector system (Craven et al., 1998). The fusion products 
were sequenced to ensure there were no frame shift mutations. The kinase-
dead allele of Nak1 was made by mutating the conserved lysine (K39) site 
in the proposed ATP binding region of the Nak1 kinase to arginine (R) using 
the Stratagene QuikChange Site-Directed Mutagenesis kit. The resulting 
constructs were sequenced to confirm the changes.
Immunoprecipitation and immunodetection
Preparation of cell extracts, immunoprecipitation, immunodetection, and ki-
nase assays were performed as described previously (Sparks et al., 1999; 
Huang et al., 2003; Kanai et al., 2005). In brief, exponentially growing 
2 x 108 cells were collected by centrifugation and cell pellets were frozen in 
liquid nitrogen. All subsequent steps were performed on ice or at 4°C. Cells 
were thawed in ice after addition of NP-40 Buffer (1% NP-40, 150 mM 
NaCl, 2 mM EDTA, 6 mM Na2HPO4, and 4 mM NaH2 PO4) supplemented 
with protease inhibitor cocktail for fungal and yeast extract (Sigma-Aldrich). 
After centrifugation for 3 min at 3,000 rpm (Beckman Coulter), 1.5 ml of 
glass beads (425–600 µm G8772 Sigma) were added to the cells and vor-
texed vigorously for 1 min. Another 1 ml of NP-40 buffer was added and the 
lysates were cleared by centrifugation at 8,000 rpm for 10 min in a micro-
fuge and the supernatant was collected. The cell lysates were subject to a 
preclearing step by incubation with 20 µl of protein G–Agarose or 15 µl 
Dyna1 beads (as appropriate, see below) by rocking at 4°C for 45 min fol-
lowed by centrifugation to collect precleared lysates. Relative protein 
amounts in the precleared lysates were estimated using the BCA Protein 
Assay kit (Thermo Fisher Scientific).
growth was also bypassed by expression of the Nak1–Orb6 fu-
sion construct, suggesting that the SIN could inhibit Mor2 func-
tion, or the ability of Nak1 or Orb6 to associate with Mor2. 
A more detailed understanding of the molecular mechanism by 
which Orb6 is activated by Nak1 will be essential to uncover 
how the SIN interferes with the activation of Orb6 and the 
MOR pathway.
The MOR inhibits SIN-mediated actomyosin 
ring constriction and septum formation
So what is the purpose of the antagonistic relationship between 
the SIN and MOR pathways? Because each signaling pathway 
directs the actin cytoskeleton toward distinct processes, the mu-
tual antagonism between them would keep each pathway from 
interfering with the functions of the other. The antagonism be-
tween the two pathways could be due to each pathway inhibiting 
signaling through the other, or by interfering with downstream 
functions such as actin organization. From our experiments, 
the SIN clearly inhibits signaling through the MOR pathway, 
although additional interference could come from competition 
over actin cytoskeletal components. In contrast, we found no 
evidence that the MOR pathway inhibited SIN signaling, but in-
stead, the MOR appears to interfere with cytokinesis downstream 
of the SIN, most likely through competition for shared compo-
nents. The antagonism between the two pathways may both en-
hance the efficiency of each pathway by removing a competitor, 
and ensure that cytoskeletal rearrangements occur at the correct 
point in the cell cycle. For example, the ability of the MOR to 
interfere with SIN functions might be important to keep weak or 
leaky SIN signaling from triggering multiple rounds of cytokine-
sis. Consistent with this, we observe that inactivation of Orb6 
allows weak interphase SIN signaling caused by the spg1-GFP 
allele to trigger ectopic septum formation. Overall, our study 
identifies an antagonistic interaction between the two NDR path-
ways, the SIN and MOR, which is crucial for the ability to main-
tain the quite different cytoskeletal arrangements present during 
cytokinesis and interphase (Fig. 6).
Animal cells also undergo redistribution of cytoskeletal 
elements as they transition between interphase and mitosis. 
Interestingly, animals also have two pathways containing NDR 
kinases analogous to the SIN and MOR pathways called the 
Hippo/Lats and Ndr1/2 pathways, respectively. Although the 
functions of these pathways in animal cells appear complex, 
they have been reported to function in mitotic exit/cytokine-
sis and polarized growth/morphogenesis as in fission yeast 
(Preisinger et al., 2004; Bothos et al., 2005; Chan et al., 2005; 
Hergovich et al., 2005, 2008; Guo et al., 2007; ten Klooster et al., 
2009). Additionally, evidence for cross talk between the homol-
ogous NDR pathways has been observed both in Drosophila 
melanogaster (Emoto et al., 2006) and in mammalian cells 
(Vichalkovski et al., 2008). Therefore, it is tempting to specu-
late that the cytoskeletal rearrangements that take place between 
anaphase/telophase and interphase might be regulated similarly 
in animal cells. Besides their role in polarized growth and 
mitotic exit, the animal homologues of the SIN and MOR path-
way components are also involved in processes regulating cell 
proliferation and cell death. The homologues of the SIN kinase 
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For immunoprecipitations of Myc-tagged Sid2, 0.2 µg anti-Myc 
monoclonal IgG (Santa Cruz Biotechnology, Inc.) was added to the NP-40 
precleared lysates (described above) and incubated on a rocker for 1 h at 
4°C. Immune complexes were prepared by adding 30 µl of a 1:1 slurry of 
protein G–Agarose beads (Sigma-Aldrich) and incubating for 1 h, followed 
by centrifugation in a microfuge for 1 min. Beads were washed three times 
with 1 ml NP-40 buffer. For immunoprecipitation of GFP-tagged Nak1 and 
Myc-tagged Mob2, precleared cell lysates in NP-40 buffer (as above) were 
added to anti-GFP monoclonal IgG (Invitrogen) or anti-Myc monoclonal 
IgG-bound magnetic protein G Dynabeads (DYNAL; Invitrogen) and incu-
bated at 4°C on a roller for at least 3 h, after which beads were washed 
three times in NP-40 buffer as before.
For detection of the epitope-tagged proteins, cell lysates and 
immunoprecipitates were separated by SDS-PAGE (7%) and transferred to 
Immobilon-P nylon (Millipore) using a wet transfer apparatus (Bio-Rad Lab-
oratories). Blots were probed with anti-Myc IgG (Santa Cruz Biotechnol-
ogy, Inc.) or anti-GFP IgG (Santa Cruz Biotechnology, Inc.) at a 1:500 
dilution, and developed using the HRP chemiluminescent detection system 
(Thermo Fisher Scientific).
In vitro kinase assays
Kinase assays were performed as described previously (Sparks et al., 
1999; Huang et al., 2003; Leonhard and Nurse, 2005). In brief, immune 
complex bead preparations were washed twice in 1 ml kinase assay buffer 
(10 mM Tris-HCl, pH 7.4, 10 mM MgCl2, 0.1 mM sodium vanadate, and 
1 mM DTT for Sid2 kinase assays; and 50 mM Tris-HCl, pH 7.4, 100 mM 
NaCl, 10 mM MgCl2, 1 mM MnCl2, and 1 mM DTT for Nak1 kinase assays) 
supplemented with a yeast protease inhibitor cocktail (Sigma-Aldrich). 
Washed immunoprecipitates were incubated at 30°C for 30 min in 20 µl 
respective kinase buffer containing 10 µg myelin basic protein (Sigma- 
Aldrich) for Sid2 kinase assays, or 5 µg -casein (Sigma-Aldrich) for Nak1 
kinase assays; 5 µCi of -[32P]ATP (PerkinElmer) and 50 µM unlabeled ATP 
per reaction. Reactions were stopped with the addition of 20 µl of 2x SDS 
sample buffer and subjected to SDS-PAGE. The gels were dried and quanti-
fied using a PhosphorImager.
Online supplemental material
Fig. S1 shows FACS plot and actin staining quantification data to show that 
SIN activation causes G2/M arrest and disrupts interphase-polarized actin 
distribution. Fig. S2 shows that immunoprecipitated untagged Mob2 does 
not have any kinase activity on MBP. Fig. S3 is the same as Fig. 3 C, with 
error bars that had been left out for clarity. Fig. S4 shows that the MOR 
pathway mutant orb6-25 does not cause persistent SIN signaling. Fig. S5 A 
shows septation counts after cell synchronization in G2 to support our con-
clusion in Fig. 5 B. Fig. S5, B and C, test the effects of Nak1–Orb6 fusion 
on septation and cell length in cdc16-116 and wild-type cells, respectively. 
Table S1 lists all the strains used in this study. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.201002055/DC1.
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